The trend in newly diagnosed Crohn's disease and extraintestinal manifestations of Crohn's disease in central China: A retrospective study of a single center

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 12, 2012, Pages 1424-1429

  Yi, Fengming ^a   Chen, Min ^a,b   Huang, Meifang ^a   Li, Jin ^a,b   Zhao, Junzhang ^b   Li, Lixia ^b   Xia, Bing ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases   (China)

Author keywords

Crohn's disease; extraintestinal manifestations; risk factors

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB;

ADULT; ANKYLOSING SPONDYLITIS; APHTHOUS STOMATITIS; ARTHRITIS; ARTICLE; CHINA; CHINESE; CLINICAL FEATURE; CROHN DISEASE; DISEASE DURATION; ERYTHEMA NODOSUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; UNIVARIATE ANALYSIS;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CHINA; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84869492200     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283583e5c     Document Type: Article

References (21)

1. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794.
2. Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011; 17:2702-2707.
3. Ricart E, Panaccione R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2004; 10:207-214.
4. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106:110-119.
5. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a populationbased study. Am J Gastroenterol 2001; 96:1116-1122.
6. Ray G. Inflammatory bowel disease in India - changing paradigms. Int J Colorectal Dis 2011; 26:635-644.
7. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170:2-6.
8. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):5-36.
9. Morita N, Toki S, Hirohashi T, Minoda T, Ogawa K, Kono S, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995; 30 (Suppl 8):1-4.
10. Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008; 14:542-549.
11. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009; 44:659-665.
12. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006; 12:212-217.
13. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia - a systematic review. J Gastroenterol Hepatol 2012; 27:1266-1280.
14. Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT registry. Inflamm Bowel Dis 2012; [Epub ahead of print].
15. Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006; 12:936-943.
16. Prideaux L, Kamm MA, De Cruz P, Williams J, Bell SJ, Connell WR, et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol 2012; 27:919-927.
17. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25- year follow-up study. World J Gatroentrol 2003; 9:2300-2307.
18. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42:387-391.
19. Torres EA, Cruz A, Monagas M, Bernal M, Correa Y, Cordero R, et al. Inflammatory bowel disease in Hispanics: the University of Puerto Rico IBD Registry. Int J Inflam 2012; 2012: 574079.
20. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006; 26:663-668.
21. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55:401-412.